Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00128700

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Klinikum der Universitaet Regensburg Regensburg, Germany
  • Azienda Ospedaliera di Padova Padova, Italy
  • Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands
View Trial Details
Completed

Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma

NCT00003916

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Alfred Hospital Melbourne, Victoria, Australia
  • Centre Antoine Lacassagne Nice, France
  • Medizinische Klinik I Dresden, Germany
  • Universitaet Wuerzburg/Hautkrankheiten Würzburg, Germany
View Trial Details
Completed

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

NCT00003731

Conditions
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Glioma, +11 more
Locations
  • Hopital Universitaire Erasme Brussels, Belgium
  • Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Centre Hospitalier Regional de Lille Lille, France
View all 24 locations
View Trial Details
Completed

Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

NCT00003775

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 26 locations
View Trial Details
Completed

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

NCT00003293

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
View all 35 locations
View Trial Details
Completed

An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies

NCT00226655

Conditions
Astrocytoma, Brain Diseases, Brain Edema, +18 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • UC Davis Medical Center, Division of Medical Oncology Sacramento, California, United States
View all 32 locations
View Trial Details

Related conditions